|
Re: Questions About Vaccinations
Hi Karen,
I wasn't on yesterday. I am in a vaccine trial at Johns Hopkins; it is peptide based specific to HER2. The lead researcher is Dr. Leisha Emmens. I'll try to find the number. She is running research both for stage 3 and 4. Not sure about the stage 4 trial, but for the st. 3 (which I am in), had to be NED to start. Good luck in your reviews. There are so many out there it is difficult to know which one is most effective.
__________________
Estelle
DX 1/09
two tumors; .7 cm and 1.0 cm, same duct
lumpectomy 2/09
10 positive nodes; scans show no further metastasis, Stage IIIc
AC completed 5/09
Tykerb/Taxol (trial) 6/09, terminated from trial (due to bad reaction to Tykerb) 8/09; switched to Herceptin/Taxol
Taxol finished 10/09
Bilateral mastectomy 11/09
Radiation 12/09 to 1/10
Herceptin finished 7/10
NED
Start Vaccine Trial at Hopkins 2/11
Finished Vaccine Trial 11/11
Continue NED
Port Out 11/11
DEIP Flap 4/17)
8 Years NED 2/17
|